CSE New Listing: Vireo Health, Cannabis Market

Dr. Kyle Kingsley, CEO and Founder of Vireo Health describes their 10 state medical cannabis operations in the U.S. …

Vireo Health, Cannabis Market

New Listing Alert! Vireo Health is now on the Canadian Securities Exchange (CSE).

Dr. Kyle Kingsley, CEO and Founder of Vireo Health describes their 10 state medical cannabis operations in the U.S.

"I'm Dr. Kyle Kingsley CEO and Founder of Vireo Health. Vireo Health is listed under the ticker VREO on the Canadian Securities Exchange.

Vireo Health is a 10 state vertically integrated medical cannabis operator in the United States.

We've focused on the highest yield states including states like New York, Pennsylvania, Ohio, Maryland Minnesota and Arizona.

Vireo will remain focused on aggressive expansion and augmentation of existing markets. Beyond our expansive high yield geographic footprint in the United States is our major focus on medicine and science. This drives amazing opportunities for us in the United States including optimized cannabis production equipment.

This drives disproportionate intellectual property opportunities that give us distinct advantages as a multi-state operator." - Kyle Kingsley, M.D.

About Vireo Health International

Vireo is America's leading science-focused, multi-state cannabis company. We are a physician-led organization dedicated to providing patients with best-in-class quality cannabis-based products and compassionate care.

Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries.

Vireo's mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry.

The Company's physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience.

Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries.

The Company is currently licensed in ten states including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island.

For more information on Vireo Health International Inc. (VREO:CSE) please fill out the form below.

You might also like

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs
Life Sciences
August 28, 2026

Lexaria Bioscience: Advancing Next-Generation Oral Weight-Loss Drugs

Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.

This is some text inside of a div block.
Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?
Finance
August 27, 2026

Brompton LCS: How Can Investors Earn Monthly Income from Canadian Life Insurers?

This is some text inside of a div block.
Brompton Funds
ETFs
August 27, 2026

Brompton Funds: Enhanced Multi-Asset Income ETF - BMAX

BMAX is designed to provide attractive monthly distributions and the opportunity for capital appreciation by investing in a portfolio of Brompton ETFs and preferred shares.

This is some text inside of a div block.
Subscribe and receive the investor Info